Home › NDC Lookup › RxCUI directory › RxCUI 1298072

Cyclopentolate hydrochloride 5 MG/ML Ophthalmic Solution — RxCUI 1298072

RxNorm drug concept · Semantic clinical drug
RxCUI 1298072 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1298072
Official nameCyclopentolate hydrochloride 5 MG/ML Ophthalmic Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascyclopentolate hydrochloride 0.5 % Ophthalmic Solution; cyclopentolate HCl 0.5 % Ophthalmic Solution
FDA products mapped3
Package NDCs mapped6
Reported Medicaid activity (SDUD)845 prescriptions · 7 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cyclopentolate Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Cyclopentolate does two important things: it widens your pupil so the provider can see the back of your eye clearly, and it stops your eye from automatically adjusting its focus. T...
  • Why is my eye care provider using these drops before my eye exam?
  • That's very normal and expected — it's actually the whole point of the drops. Your ability to focus should return within 6 to 24 hours for most people. Your pupil may stay wider th...
  • How long will my vision be blurry and my eyes sensitive to light?
📖 Read our full Cyclopentolate Ophthalmic guide →

🕸️ Concept Web — How Cyclopentolate hydrochloride 5 MG/ML Ophthalmic... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Cyclopentolate hydrochloride 5 MG/ML Ophthalmic Solution RxCUI 1298072

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Cyclopentolate 3001
    • Cyclopentolate hydrochloride 106029
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Cyclogyl 2984
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cyclopentolate Ophthalmic Solution 377444
    • Cyclopentolate hydrochloride Ophthalmic Solution 2648756
    • Cyclopentolate Ophthalmic Product 1156179
    • Cyclopentolate hydrochloride Ophthalmic Product 2663518
    • Cyclopentolate Ophthalmic Solution [Cyclogyl] 363840
    • Cyclopentolate hydrochloride Ophthalmic Solution [Cyclogyl] 2657986
    • Cyclogyl Ophthalmic Product 1173740
    • Ophthalmic Solution 7670
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Cyclopentolate hydrochloride 5 MG/ML SCDC · 1298071
  • Cyclopentolate Ophthalmic Solution SCDF · 377444
  • Cyclopentolate hydrochloride Ophthalmic Solution SCDFP · 2648756
  • Cyclopentolate Ophthalmic Product SCDG · 1156179
  • Cyclopentolate hydrochloride Ophthalmic Product SCDGP · 2663518

Brand-Name Concepts

  • Cyclopentolate hydrochloride 5 MG/ML Ophthalmic Solution [Cyclogyl] SBD · 1298366
  • Cyclopentolate hydrochloride 5 MG/ML [Cyclogyl] SBDC · 1298365
  • Cyclopentolate Ophthalmic Solution [Cyclogyl] SBDF · 363840
  • Cyclopentolate hydrochloride Ophthalmic Solution [Cyclogyl] SBDFP · 2657986
  • Cyclogyl Ophthalmic Product SBDG · 1173740
  • Cyclogyl BN · 2984

📦 FDA Products & Package NDCs

3 products · 6 package NDCs
6 package NDCs map to RxCUI 1298072 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00065-0395-15 1 BOTTLE, PLASTIC in 1 CARTON (0065-0395-15) / 15 mL in 1 B... Cyclogyl Alcon Laboratories, Inc. 1975-10-15
00065-0396-02 1 BOTTLE, PLASTIC in 1 CARTON (0065-0396-02) / 2 mL in 1 BO... Cyclogyl Alcon Laboratories, Inc. 1975-10-15
00065-0396-05 1 BOTTLE, PLASTIC in 1 CARTON (0065-0396-05) / 5 mL in 1 BO... Cyclogyl Alcon Laboratories, Inc. 1975-10-15
00065-0397-02 1 BOTTLE, PLASTIC in 1 CARTON (0065-0397-02) / 2 mL in 1 BO... Cyclogyl Alcon Laboratories, Inc. 1975-10-15
00065-0397-05 1 BOTTLE, PLASTIC in 1 CARTON (0065-0397-05) / 5 mL in 1 BO... Cyclogyl Alcon Laboratories, Inc. 1975-10-15
00065-0397-15 1 BOTTLE, PLASTIC in 1 CARTON (0065-0397-15) / 15 mL in 1 B... Cyclogyl Alcon Laboratories, Inc. 1975-10-15
Observed labelers: Alcon Laboratories, Inc. (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.